Blog
RSS FeedPosted by Michael Wonder on 15 Jul 2024
Onco360 selected as a limited distribution specialty pharmacy partner for Rytelo (imetelstat)
12 July 2024 - Onco360 has been selected as a pharmacy partner by Geron Corporation for Rytelo (imetelstat) as a ...
Posted by Michael Wonder on 14 Sep 2023
Elrexfio (elranatamab-bcmm), now available from Onco360
13 September 2023 - Has received FDA accelerated approval for the treatment of adult patients with relapsed or refractory multiple myeloma ...
Posted by Michael Wonder on 19 Sep 2022
Pharmacists can now prescribe Paxlovid, but barriers persist
19 September 2022 - Recently, the FDA expanded access to COVID-19 treatment by authorising state-licensed pharmacists to prescribe Paxlovid to eligible ...
Posted by Michael Wonder on 06 Jul 2022
FDA authorises pharmacists to prescribe Paxlovid with certain limitations
6 July 2022 - New prescribing authority could improve access for some patients at high risk for severe COVID-19. ...
Posted by Michael Wonder on 21 Aug 2021
Competition, consolidation and evolution in the pharmacy market
12 August 2021 - Implications for efforts to contain drug prices and spending. ...
Posted by Michael Wonder on 17 Dec 2020
Hospitals discover a surprise in their vaccine deliveries: extra doses
16 December 2020 - Pharmacists have found that they can squeeze an additional dose from some of the glass vials that ...
Posted by Michael Wonder on 30 Nov 2020
Pharmacies add freezers, train staff to handle COVID-19 vaccination drive
29 November 2020 - Many supermarkets have offered customers flu shots for years, but COVID-19 vaccine distribution will require more coordination ...
Posted by Michael Wonder on 28 Jun 2018
Statement from FDA Commissioner on agency’s continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug
28 June 2018 - As a physician, I understand how important it can be for health care providers to treat ...